Cargando…

The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics

The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Engen, Nicholas K, Engelken, Terry J, Lockard, Caleb G, Lakritz, Jeffery, Cernicchiaro, Natalia, Wilson, Blake K, Krehbiel, Clint R, Coetzee, Johann F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200945/
https://www.ncbi.nlm.nih.gov/pubmed/32704832
http://dx.doi.org/10.1093/tas/txz070
_version_ 1783529443347660800
author Van Engen, Nicholas K
Engelken, Terry J
Lockard, Caleb G
Lakritz, Jeffery
Cernicchiaro, Natalia
Wilson, Blake K
Krehbiel, Clint R
Coetzee, Johann F
author_facet Van Engen, Nicholas K
Engelken, Terry J
Lockard, Caleb G
Lakritz, Jeffery
Cernicchiaro, Natalia
Wilson, Blake K
Krehbiel, Clint R
Coetzee, Johann F
author_sort Van Engen, Nicholas K
collection PubMed
description The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at harvest in cross bred beef cattle. Multisourced, crossbred steer calves (n = 168) consisting of mainly British and British-Continental breeds were purchased from an auction market in central Missouri. Calves were processed prior to transportation and again upon feedlot arrival. Animals were randomized to 3 separate treatments: pretransport meloxicam (PMEL), arrival meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Dosing at 1 mg/kg on weighted averaged administered per os. Animals were weighed and blood was collected pre- and post-transport. Haptoglobin (Hp)-matrix metaloproteinase (MMP)-9 complex, cortisol, and substance P were quantified. Weights were taken again at 42 d and at harvest. Clinical signs of BRD were monitored using indicators of depression, appetite, respiration, and temperature that qualified the animals for treatment. Harvest parameters were collected using a standardized United States Department of Agriculture grading system for quality grade and yield grade. Meloxicam did not have a significant effect on BRD morbidity over the course of the study and there was no significant effect on performance characteristics at 42 d (P > 0.10). Of the calves that did succumb to BRD, no significant differences were found in severity of disease (P > 0.10). Concentrations of substance P and Hp- MMP-9, were increased on arrival (P ≤ 0.05) however no significant treatment effect or interaction were found between AMEL, PMEL, CONT, or across different levels of biomarkers (P > 0.10). Meloxicam use prior to or on arrival does not mitigate disease or improve performance during the feeding period.
format Online
Article
Text
id pubmed-7200945
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72009452020-07-22 The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics Van Engen, Nicholas K Engelken, Terry J Lockard, Caleb G Lakritz, Jeffery Cernicchiaro, Natalia Wilson, Blake K Krehbiel, Clint R Coetzee, Johann F Transl Anim Sci Animal Health And Well Being The objective of this trial was to investigate the effects of using meloxicam as a pretransport or on arrival therapeutic on disease outcomes of bovine respiratory disease (BRD), biomarker outcomes associated with BRD, performance characteristics over the first 42 d on feed, and carcass traits at harvest in cross bred beef cattle. Multisourced, crossbred steer calves (n = 168) consisting of mainly British and British-Continental breeds were purchased from an auction market in central Missouri. Calves were processed prior to transportation and again upon feedlot arrival. Animals were randomized to 3 separate treatments: pretransport meloxicam (PMEL), arrival meloxicam (AMEL), and a control group receiving inactive excipient (CONT). Dosing at 1 mg/kg on weighted averaged administered per os. Animals were weighed and blood was collected pre- and post-transport. Haptoglobin (Hp)-matrix metaloproteinase (MMP)-9 complex, cortisol, and substance P were quantified. Weights were taken again at 42 d and at harvest. Clinical signs of BRD were monitored using indicators of depression, appetite, respiration, and temperature that qualified the animals for treatment. Harvest parameters were collected using a standardized United States Department of Agriculture grading system for quality grade and yield grade. Meloxicam did not have a significant effect on BRD morbidity over the course of the study and there was no significant effect on performance characteristics at 42 d (P > 0.10). Of the calves that did succumb to BRD, no significant differences were found in severity of disease (P > 0.10). Concentrations of substance P and Hp- MMP-9, were increased on arrival (P ≤ 0.05) however no significant treatment effect or interaction were found between AMEL, PMEL, CONT, or across different levels of biomarkers (P > 0.10). Meloxicam use prior to or on arrival does not mitigate disease or improve performance during the feeding period. Oxford University Press 2019-05-13 /pmc/articles/PMC7200945/ /pubmed/32704832 http://dx.doi.org/10.1093/tas/txz070 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the American Society of Animal Science. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Animal Health And Well Being
Van Engen, Nicholas K
Engelken, Terry J
Lockard, Caleb G
Lakritz, Jeffery
Cernicchiaro, Natalia
Wilson, Blake K
Krehbiel, Clint R
Coetzee, Johann F
The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title_full The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title_fullStr The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title_full_unstemmed The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title_short The effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
title_sort effects of pretransportation or arrival meloxicam administration to calves entering the feedlot on morbidity, biomarkers, performance, and carcass characteristics
topic Animal Health And Well Being
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200945/
https://www.ncbi.nlm.nih.gov/pubmed/32704832
http://dx.doi.org/10.1093/tas/txz070
work_keys_str_mv AT vanengennicholask theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT engelkenterryj theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT lockardcalebg theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT lakritzjeffery theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT cernicchiaronatalia theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT wilsonblakek theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT krehbielclintr theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT coetzeejohannf theeffectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT vanengennicholask effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT engelkenterryj effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT lockardcalebg effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT lakritzjeffery effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT cernicchiaronatalia effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT wilsonblakek effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT krehbielclintr effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics
AT coetzeejohannf effectsofpretransportationorarrivalmeloxicamadministrationtocalvesenteringthefeedlotonmorbiditybiomarkersperformanceandcarcasscharacteristics